MIZUHO MEDY CO.,LTD. Logo

MIZUHO MEDY CO.,LTD.

Develops and manufactures in-vitro diagnostic products like immunoassays and gene tests.

4595 | T

Overview

Corporate Details

ISIN(s):
JP3885900005
LEI:
Country:
Japan
Address:
鳥栖市藤木町5番地の4

Description

MIZUHO MEDY CO.,LTD. is a company that specializes in the research, development, manufacture, and sale of in-vitro diagnostic (IVD) products. The company's portfolio is centered on two main technologies: rapid immunoassays and nucleic acid amplification tests. Its rapid immunoassay product line includes the 'Quick Chaser' series for the detection of infectious diseases such as influenza, RSV, and SARS-CoV-2, as well as consumer-oriented products like pregnancy and ovulation test kits. In the molecular diagnostics segment, the company offers nucleic acid amplification test products, including the 'Smart Gene®' system, and develops related equipment like fully automated gene analysis instruments. Mizuho Medy serves various sectors, including medical diagnostics, research, and agriculture.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2018-11-09 05:05
四半期報告書-第42期第3四半期(2018/07/01-2018/09/30)
Japanese 150.0 KB
2018-08-10 05:59
四半期報告書-第42期第2四半期(2018/04/01-2018/06/30)
Japanese 179.1 KB
2018-05-11 06:38
四半期報告書-第42期第1四半期(2018/01/01-2018/03/31)
Japanese 148.0 KB
2018-03-30 03:00
有価証券報告書-第41期(平成29年1月1日-平成29年12月31日)
Japanese 774.0 KB
2017-11-13 05:09
四半期報告書-第41期第3四半期(2017/07/01-2017/09/30)
Japanese 150.2 KB
2017-08-10 06:30
四半期報告書-第41期第2四半期(2017/04/01-2017/06/30)
Japanese 182.5 KB
2017-05-12 06:25
四半期報告書-第41期第1四半期(2017/01/01-2017/03/31)
Japanese 143.8 KB
2017-03-30 03:00
有価証券報告書-第40期(2016/01/01-2016/12/31)
Japanese 739.9 KB
2016-11-10 07:10
四半期報告書-第40期第3四半期(2016/07/01-2016/09/30)
Japanese 141.8 KB
2016-08-10 08:09
四半期報告書-第40期第2四半期(2016/04/01-2016/06/30)
Japanese 177.8 KB
2016-05-13 02:05
四半期報告書-第40期第1四半期(2016/01/01-2016/03/31)
Japanese 145.8 KB
2016-03-30 03:03
有価証券報告書-第39期(2015/01/01-2015/12/31)
Japanese 691.9 KB

Automate Your Workflow. Get a real-time feed of all MIZUHO MEDY CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MIZUHO MEDY CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MIZUHO MEDY CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.